Related Experiment Video
Updated: Nov 21, 2025

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.9K
Exploring the five different genes associated with PKCα in bladder cancer based on gene expression microarray.
Xiaotong Zhang1, Jiarun Zhang1, Hao Zhang1
1Department of Urology, The First Hospital of China Medical University, Shenyang, China.
Journal of Cellular and Molecular Medicine
|January 16, 2021
Summary
Protein kinase C-alpha (PKCα) drives bladder cancer progression by promoting cell proliferation and inhibiting apoptosis. Targeting PKCα offers a potential therapeutic strategy for bladder cancer by modulating key downstream genes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Protein kinase C-alpha (PKCα) is an oncogene implicated in various cancers.
- Its specific role and regulatory mechanisms in bladder cancer (BC) progression are not fully understood.
Purpose of the Study:
- To investigate the role of PKCα in bladder cancer progression.
- To identify downstream genes regulated by PKCα in bladder cancer cells.
Main Methods:
- Utilized PKCα siRNA to down-regulate gene expression in vitro.
- Employed cDNA microarray technology to analyze differential gene expression.
- Performed in vivo tumor growth studies.
- Conducted correlation analysis and pathway analysis.
Main Results:
- Down-regulation of PKCα inhibited cell proliferation, migration, and invasion, while inducing apoptosis and G1/S cell cycle arrest.
- Overexpression of PKCα promoted tumor growth in vivo.
- Identified five key downstream genes (BIRC2, BIRC3, CDK4, TRAF1, BMP4) involved in proliferation and apoptosis.
- PKCα regulates proliferation and apoptosis via the NF-kB signaling pathway.
Conclusions:
- PKCα plays a critical role in bladder cancer progression by regulating cell proliferation and apoptosis.
- PKCα influences the expression of BIRC2, BIRC3, CDK4, TRAF1, and BMP4.
- Targeting PKCα may represent a viable therapeutic strategy for bladder cancer.

